The WTO waiver battle over Covid jab IP rights
Sudden US backing for a global waiver on patent protections for COVID-19 vaccines offers hope to poor nations struggling for doses—but the big pharma industry thinks the notion misguided.
- Next story Facebook Ducks the Big Issue
- Previous story Tell Us: Do You Want Children?
Explore more
- Recording brain activity with laser light
A Caltech professor, in collaboration with researchers at the University of Southern... - Son of Bo Schembechler Says He Was Abused by Team Doctor at Michigan
Matt Schembechler said his account of abuse when he was a child... - All Americans 16 years and older are eligible for Covid-19 vaccines starting today
- NASA video shows Mars helicopter’s historic first flight
NASA has released a high-definition video showing the Ingenuity Mars helicopter taking... - Biden to Withdraw All Combat Troops From Afghanistan by Sept. 11
After years of arguing against an extended military presence in Afghanistan, President... - College Players Graduating to the N.H.L. Have a Chance for Longer Test Run
The modified schedule gives college players who make N.H.L. rosters an opportunity... - The Nets’ Starters Are Back Together. And So Are the Fans.
Over 14,000 fans attended Game 1 of the Nets-Celtics series as Kevin... - India bans export of COVID-19 treatment drug remdesivir
India on Sunday banned the export of remdesivir as infections soared to... - Fed Minutes April 2021: Officials Hint They Might Soon Talk About Slowing Bond-Buying
Minutes from the Federal Reserve’s April meeting showed some officials wanted to... - Bernie Madoff, infamous Ponzi schemer, has died
